<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:og="http://ogp.me/ns#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:schema="http://schema.org/" xmlns:sioc="http://rdfs.org/sioc/ns#" xmlns:sioct="http://rdfs.org/sioc/types#" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" version="2.0" xml:base="https://rtaylor193.github.io/insureintell-1col/">
  <channel>
    <title>type d personality</title>
    <link>https://rtaylor193.github.io/insureintell-1col/</link>
    <description/>
    <language>en</language>
    
    <item>
  <title>Type D Personality</title>
  <link>https://rtaylor193.github.io/insureintell-1col/node/25653</link>
  <description>  &lt;div data-history-node-id="25653" class="layout layout--onecol"&gt;
    &lt;div class="layout__region layout__region--content"&gt;
      
  &lt;div&gt;
    &lt;div&gt;Body&lt;/div&gt;
              &lt;div property="schema:text"&gt;&lt;p&gt;&lt;strong&gt;Why is this subject important?&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;&lt;em&gt;“Growing evidence indicated that negative emotions may influence the development of CHD.”&lt;/em&gt;&lt;/p&gt;

&lt;blockquote&gt;
&lt;p&gt;L. D. Kubzansky and I. Kawachi&lt;br /&gt;
Harvard School of Public Health&lt;br /&gt;
&lt;em&gt;Journal of Psychosomatic Research&lt;/em&gt;&lt;br /&gt;
48(2000):323&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;&lt;em&gt;“Type D personality was an independent predictor of adverse events in patients optimally treated with the latest &lt;/em&gt;[therapies]&lt;em&gt; in interventional cardiology.”&lt;/em&gt;&lt;/p&gt;

&lt;blockquote&gt;
&lt;p&gt;Susanne S Pedersen, PhD, et al.&lt;br /&gt;
Rotterdam, The Netherlands&lt;br /&gt;
&lt;em&gt;The American Journal of Cardiology&lt;/em&gt;&lt;br /&gt;
44(2004):997&lt;/p&gt;
&lt;/blockquote&gt;
&lt;!--break--&gt;&lt;!--break--&gt;

&lt;p&gt; &lt;/p&gt;

&lt;p&gt;&lt;strong&gt;What is Type D personality?&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;An emerging diagnostic entity – also called distressed personality – based on two broad and stable traits: negative affect and social inhibition.&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;Is Type D now regarded as a distinctive entity? &lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;Yes. [Kudielka]&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;Is it included in DSM-IV as a clinical diagnostic entity in psychiatric medicine?&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;No…at least not yet. But, then, neither is Type A personality, which has been around for over 20 years!&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;How is the presence of this disorder established?&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;Using a 14-item rating scale known as DS14.&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;What is the prevalence of Type D personality (hereafter referred to simply as TDP) using the DS14 scale?&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;In a Dutch study involving 3813 subjects, it was 21% overall. [Denollet, 2005]&lt;/p&gt;

&lt;p&gt;In a British/Irish study, of 1012 healthy young adults, it was 38.5%. [Williams]&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;Is TDP inherited?&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;In the only study we could find, involving 3331 adult twin pairs, the experts estimated that just over 50% of TDP was inherited, with the remained being acquired during life. [Kupper]&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;What features are associated with TDP – that is, in addition to negative affect and social isolation? &lt;/strong&gt;[Karlsson, Pedersen + Daemen]&lt;/p&gt;

&lt;ul&gt;
	&lt;li&gt;Pessimism&lt;/li&gt;
	&lt;li&gt;Mental vulnerability&lt;/li&gt;
	&lt;li&gt;Excessive worry&lt;/li&gt;
	&lt;li&gt;Gloominess&lt;/li&gt;
	&lt;li&gt;Discomfort with strangers&lt;/li&gt;
	&lt;li&gt;Mental exhaustion&lt;/li&gt;
	&lt;li&gt;Lowered sense of coherence&lt;/li&gt;
	&lt;li&gt;Anxiety and depression symptoms&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;&lt;strong&gt;Does TDP affect many aspects of quality of life?&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;Aquarius found that it significantly and adversely impacted all 10 variables measured, including pain and discomfort, sleep and rest, ADLs, work capacity, etc.&lt;/p&gt;

&lt;p&gt;Clearly, TDP has major unfavorable risk implications for disability (income protection) insurability.&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;Are TDP patients less likely to engage in a health lifestyle?&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;We know they are significantly more likely to smoke and there is evidence that other lifestyle factors are likely adversely affected as well. [Pedersen and Denollet]&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;What other significant adversities are associated with TDP in terms of daily life?&lt;/strong&gt;&lt;/p&gt;

&lt;ul&gt;
	&lt;li&gt;They are less likely to benefit from medical care. [Song]&lt;/li&gt;
	&lt;li&gt;Adolescents with TDP were found to have significantly more somatic complaints. [Jellesma]&lt;/li&gt;
	&lt;li&gt;They are more likely to have both false-positive and false-negative results on memory tests and similar types of tests, due to a lack of effort. [Stulemeijer]&lt;/li&gt;
	&lt;li&gt;Those with chronic disease are less likely to consult a physician regarding the onset of new symptoms. [Schiffer, 2007]&lt;/li&gt;
	&lt;li&gt;They perceive the workplace as more stressful than other individuals, have more symptoms due to workplace stress and have a higher incidence of work-related “burnout.” [Ogińska-Bulik]&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;&lt;strong&gt;Is pessimism – a prevalent TDP finding – associated with extra mortality?&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;There is evidence to suggest it is. [Gitlay, Maruta]&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;What is mental vulnerability?&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;Based on a mental vulnerability scale developed in Denmark, it is associated with psychosomatic reactions and negative reactions to social interactions. The subject is physically and emotionally vulnerable in context with typical daily social intercourse.&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;Is mentality vulnerability a prominent feature in TDP?&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;Yes.&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;What problems are associated with patients diagnosed with mental vulnerability?&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;A Copenhagen study reported the following findings based on a study population of 6435 individuals who were assessed in one of three categories: not vulnerable, moderately vulnerable and highly vulnerable. [Eplov]&lt;/p&gt;

&lt;p&gt;Those who were deemed highly vulnerable were:&lt;/p&gt;

&lt;ul&gt;
	&lt;li&gt;More sedentary&lt;/li&gt;
	&lt;li&gt;Less likely to be married or cohabitating&lt;/li&gt;
	&lt;li&gt;More likely to be heavy smokers&lt;/li&gt;
	&lt;li&gt;Less likely to come from the highest 2 of 5 socioeconomic classes&lt;/li&gt;
	&lt;li&gt;Consumed less alcohol&lt;/li&gt;
	&lt;li&gt;Had substantially greater morbidity&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;&lt;strong&gt;Was mortality impacted by high mental vulnerability?&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;Yes, compared to non-vulnerable subjects, those who were highly vulnerable had: [Eplov]&lt;/p&gt;

&lt;ul&gt;
	&lt;li&gt;2-fold higher all-cause mortality&lt;/li&gt;
	&lt;li&gt;3.5 x the risk of fatal accidents and suicide&lt;/li&gt;
	&lt;li&gt;60% greater cancer mortality&lt;/li&gt;
	&lt;li&gt;2-fold higher cardiovascular mortality&lt;/li&gt;
	&lt;li&gt;Nearly 3 times the risk of death from “other causes”&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;&lt;strong&gt;Is TDP strongly associated with comorbid depression?&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;Yes. [Kuijpers]&lt;/p&gt;

&lt;p&gt;In addition, the incidence of depression increases dramatically in persons who have both TDP and an anxiety disorder. [Pedersen]&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;Has any factor been identified which significantly increases the risk of anxiety and depression in subjects with TDP?&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;Yes – not having a partner (spouse or cohabitator). [van den Broek]&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;Is there any current treatment used in TDP?&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;If there is, we couldn’t find out what it is.&lt;/p&gt;

&lt;p&gt;Most likely, persons with TDP are only treated when they have a comorbid diagnosis. Since the most prevalent comorbidities are depression and anxiety disorders, likely most of these individuals would be given garden-variety antidepressants and, in some cases, antianxiety drugs such as benzodiazepines.&lt;/p&gt;

&lt;p&gt; &lt;/p&gt;

&lt;p&gt;&lt;strong&gt;Type D Personality And Non-Psychiatric Disorders&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;Is TDP considered a risk factor for CAD?&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;&lt;em&gt;“Type D personality…is an emerging risk factor for CVD that has been linked to the onset of depressive symptoms and an increased risk of morbidity and mortality.”&lt;/em&gt;&lt;/p&gt;

&lt;p&gt;Susanne S. Pederson, PhD, et al.&lt;br /&gt;
&lt;em&gt;European Journal of Cardiovascular Prevention and Rehabilitation&lt;/em&gt;&lt;br /&gt;
15(2008):203&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;Which aspect of TDP is most strongly associated with increased CV risk?&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;Negative affect…which is associated with a 2.3-fold greater risk than positive affect. [Langer]&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;What factors are thought to drive the increased CV risk in TPD?&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;This continues to be investigated as TDP is a relatively newly-recognized entity as compared, for example, to Type A personality.&lt;/p&gt;

&lt;p&gt;Thus far, three factors have been suggested as drivers for this:&lt;/p&gt;

&lt;ul&gt;
	&lt;li&gt;Increased release of cortisol [Whitehead]&lt;/li&gt;
	&lt;li&gt;Psychological hyperreactivity [Habra] – which would be at least in part driven by excess cortisol&lt;/li&gt;
	&lt;li&gt;Chronic inflammation, which has been shown to be present based on several biomarkers [Deswal]&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;&lt;strong&gt;Does the presence of a Type D (TDP) predict for an increased risk of depression onset in CV patients? &lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;Yes [Schiffer]…and this is highly significant given the strong adverse association between clinical depression and CV disease outcomes.&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;To what extent does the presence of TDP increase the risk of cardiac events in patients with CAD?&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;In a 2006 study, TDP nearly tripled the risk! [Denollet and Pedersen]&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;Is TDP a risk factor for early MI?&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;In a small Iranian study, the risk of MI prior to age 50 was 3-fold greater in those with TDP. [Pezeshki]&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;In which other circulatory disease contexts has TDP been shown to have adverse implications?&lt;/strong&gt;&lt;/p&gt;

&lt;ul&gt;
	&lt;li&gt;2-fold increased risk of subsequent events and death following CABG (bypass surgery). [Pedersen, 2007]&lt;/li&gt;
	&lt;li&gt;2.5-fold increased risk of hypertension. [Denollet, 2005]&lt;/li&gt;
	&lt;li&gt;2-fold increased risk of lone atrial fibrillation. [Hatzinikolaou-Kotsakou]&lt;/li&gt;
	&lt;li&gt;Increased prevalence of syndrome X (chest pain with normal coronary arteries). [Kuijpers]&lt;/li&gt;
	&lt;li&gt;Less favorable prognosis in PAD, even after adjusting for ankle-brachial index (ABI). [Aquarius and Denollet]&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;&lt;strong&gt;Are there any other non-psychiatric impairments linked to TDP?&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;It is important here to understand that research on TDP has not been going on to any significant degree for more than a decade. It is likely that further evidence connecting TDP and medical impairments will become known in the years ahead.&lt;/p&gt;

&lt;p&gt;This said, research thus far has connected TDP to:&lt;/p&gt;

&lt;ul&gt;
	&lt;li&gt;An increased risk of cancer – but the data are based only on 2 small studies and thus may not stand the test of further scrutiny. [Realdi; Denollet, 1998]&lt;/li&gt;
	&lt;li&gt;Less favorable health status in patients with irritable bowel syndrome. [Hansel]&lt;/li&gt;
	&lt;li&gt;Increased risk of recurrence in vulvovaginal candidiasis. [Ehrström]&lt;/li&gt;
	&lt;li&gt;Decreased compliance with CPAP (continuous positive airway pressure therapy) in obstructive sleep apnea. [Broström]&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt; &lt;/p&gt;

&lt;p&gt;&lt;strong&gt;Underwriting Implications of Type D Personality Disorder&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;What do we know so far?&lt;/strong&gt;&lt;/p&gt;

&lt;ul&gt;
	&lt;li&gt;It is unlikely that TDP will be diagnosed more than rarely at this time – however, this may change in the near future as more studies are done.&lt;/li&gt;
	&lt;li&gt;The manifestations of TDP are consistent with substantial excess morbidity for both disability (income protection) and health (medical) insurance.9&lt;/li&gt;
	&lt;li&gt;The association with CAD, and possible greater risk of cancer, makes TDP an unfavorable risk factor for critical illness insurance.&lt;/li&gt;
	&lt;li&gt;TDP increases the adversity of both anxiety and mood disorders, but the magnitude of its impact remains to be defined.&lt;/li&gt;
	&lt;li&gt;Like depression, the presence of TDP – or its features in the absence of a stated diagnosis – is a notable risk factor for developing CAD as well as a worse outcome in patients with known CAD.&lt;/li&gt;
	&lt;li&gt;Its links to other CV impairments underscores its overall risk importance in all major domains of L+H underwriting.&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;&lt;strong&gt;How would TDP influence our underwriting assessments?&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;In the rare case – for now, anyway – where there is sufficient information to establish that the major features of TDP are present, one could clearly justify using it to negatively influence the final underwriting decision.&lt;/p&gt;

&lt;p&gt;In the future, we should have more insight into Type D personality and its longer-term risk implications.&lt;/p&gt;

&lt;p&gt;In the meantime, we hope you found at least some of this report to be of value!&lt;/p&gt;

&lt;p&gt; &lt;/p&gt;

&lt;p&gt;&lt;strong&gt;References&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;Aquarius. &lt;em&gt;The American Journal of Cardiology&lt;/em&gt;. 96(2005):996&lt;br /&gt;
Aquarius and Denollet.&lt;em&gt; Journal of Vascular Surgery.&lt;/em&gt; 46(2007):507&lt;br /&gt;
Broström. &lt;em&gt;Journal of Sleep Research.&lt;/em&gt; 16(2007):439&lt;br /&gt;
Denollet, 1998. &lt;em&gt;Psychological Medicine.&lt;/em&gt; 28(1998):991&lt;br /&gt;
Denollet, 2005. &lt;em&gt;Psychosomatic Medicine.&lt;/em&gt; 67(2005):89&lt;br /&gt;
Denollet and Pedersen. &lt;em&gt;The American Journal of Cardiology.&lt;/em&gt; 97(2006):970&lt;br /&gt;
Deswal. &lt;em&gt;Circulation. &lt;/em&gt;103(2001):2055&lt;br /&gt;
Ehrström. &lt;em&gt;Journal of Psychosomatic Obstetrics and Gynecology&lt;/em&gt;. 28(2007):169&lt;br /&gt;
Eplov.&lt;em&gt; Epidemiology.&lt;/em&gt; 16(2005):226&lt;br /&gt;
Gitlay.&lt;em&gt; Archives of Internal Medicine. &lt;/em&gt;166(2006):431&lt;br /&gt;
Habra.&lt;em&gt; Journal of Psychosomatic Research.&lt;/em&gt; 55(2003):235&lt;br /&gt;
Hansel.&lt;strong&gt; &lt;/strong&gt;&lt;em&gt;American Journal of Gastroenterology&lt;/em&gt;&lt;strong&gt;. &lt;/strong&gt;102, Supplement 2(2007):S510&lt;br /&gt;
Hatzinikolaou-Kotsakou. &lt;em&gt;European Journal of Cardiovascular Preventiomn and Rehabilitation.&lt;/em&gt; 14, Supplement 1(2007):S52&lt;br /&gt;
Jellesma. &lt;em&gt;Journal of Developmental and Behavioral Pediatrics.&lt;/em&gt; 29(2008):94&lt;br /&gt;
Karlsson. &lt;em&gt;Journal of Behavioral Medicine. &lt;/em&gt;30(2007):253&lt;br /&gt;
Kudielka. &lt;em&gt;Behavioral Medicine. &lt;/em&gt;30(2004):35&lt;br /&gt;
Kuijpers. &lt;em&gt;European Journal of Cardiovascular Prevention and Rehabilitation.&lt;/em&gt; 14(2007):273&lt;br /&gt;
Kupper. &lt;em&gt;Psychosomatic Medicine.&lt;/em&gt; 69(2007):675&lt;br /&gt;
Langer. &lt;em&gt;Circulation&lt;/em&gt;. 112, Supplement 2(2005):II-426&lt;br /&gt;
Maruta. &lt;em&gt;Mayo Clinic Proceedings.&lt;/em&gt; 75(2000):140&lt;br /&gt;
Ogińska-Bulik. &lt;em&gt;International Journal of Occupational Medicine and Environmental Health. &lt;/em&gt;19(2006):113&lt;br /&gt;
Pedersen.&lt;em&gt; European Journal of Cardiovascular Prevention and Rehabilitation.&lt;/em&gt; 15(2008):203&lt;br /&gt;
Pedersen, 2007.&lt;em&gt; European Journal of Cardiovascular Prevention and Rehabilitation.&lt;/em&gt; 14(2007):135&lt;br /&gt;
Pedersen and Daemen. &lt;em&gt;Journal of Psychosomatic Research.&lt;/em&gt; 62(2007):447&lt;br /&gt;
Pedersen and Denollet. &lt;em&gt;European Journal of Cardiovascular Prevention and Rehabilitation.&lt;/em&gt; 14(2007):135&lt;br /&gt;
Pezeshki.&lt;em&gt; American Journal of Epidemiology.&lt;/em&gt; 163, Supplement(2006):S211&lt;br /&gt;
Realdi.&lt;em&gt; High Blood Pressure and Cardiovascular Prevention. &lt;/em&gt;14(2007):185&lt;br /&gt;
Schiffer. &lt;em&gt;European Journal of Cardiovascular Prevention and Rehabilitation.&lt;/em&gt;12(2005):341&lt;br /&gt;
Schiffer, 2007. &lt;em&gt;Heart. &lt;/em&gt;93(2007):814&lt;br /&gt;
Song. &lt;em&gt;Taehan Kanho Hakhoe Chi. &lt;/em&gt;38(2008):19&lt;br /&gt;
Stulemeijer. &lt;em&gt;Brain Injury.&lt;/em&gt; 21(2007):309&lt;br /&gt;
van den Broek.&lt;em&gt; Journal of Psychosomatic Research.&lt;/em&gt; 63(2007):41&lt;br /&gt;
Whitehead. &lt;em&gt;Journal of Psychosomatic Research. &lt;/em&gt;62(2007):419&lt;br /&gt;
Williams. &lt;em&gt;Journal of Psychosomatic Research.&lt;/em&gt; 64(2008):63&lt;/p&gt;
&lt;/div&gt;
          &lt;/div&gt;

    &lt;/div&gt;
  &lt;/div&gt;

</description>
  <pubDate>Tue, 01 Jul 2008 13:01:09 +0000</pubDate>
    <dc:creator>hankgeorge</dc:creator>
    <guid isPermaLink="false">25653 at https://rtaylor193.github.io/insureintell-1col</guid>
    </item>

  </channel>
</rss>
